Efficiency And Tolerance Of Hazelnut Oral Immunotherapy Protocol In Hazelnut Allergic Children

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

April 1, 2021

Study Completion Date

May 15, 2021

Conditions
Allergy, NutPediatric ALL
Interventions
OTHER

Clinical and biological characteristics

"* Age at beginning of IOT~* Sex~* Atopic and non atopic Comorbidities~* Sensitization to aero-allergens~* Sensitization to trophallergens~* Stage of severity of the elicited reaction~* Hazelnut Specific IgE + Cor a 1,8,9,14 before IOT and during follow up~* Hazelnut skin prick test before IOT and during follow up~* Adverse effects of IOT and their stage (in hospital and at home)~* Use of adrenaline auto-injector (in hospital and at home)~* Maintenance dose"

Trial Locations (1)

69500

Pneumology allergology-paediatric department of the Mother and Child Hospital, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04841850 - Efficiency And Tolerance Of Hazelnut Oral Immunotherapy Protocol In Hazelnut Allergic Children | Biotech Hunter | Biotech Hunter